Skip to main content
. 2021 Oct 12;27(2):1136–1144. doi: 10.1038/s41380-021-01334-4

Fig. 4. Discontinuation due to inefficacy.

Fig. 4

Drugs were compared with the placebo. Colors indicate the presence or absence of a significant difference: blue, the drug was superior to the placebo; black, the drug was similar to the placebo. 95% CI 95% confidence interval, ARI aripiprazole, ASE asenapine, BRE brexpiprazole, CARB carbamazepine, CARI cariprazine, HAL haloperidol, LAM lamotrigine, LIT lithium, OLA olanzapine, PAL paliperidone, QUE quetiapine, RIS risperidone, RR risk ratio, TAM tamoxifen, TOP topiramate, VALN valnoctamide, VALP valproate, VER verapamil, ZIP ziprasidone.